array file maker 4.0 software Search Results


microarray imager software  (CombiMatrix)
90
CombiMatrix microarray imager software
Microarray Imager Software, supplied by CombiMatrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray imager software/product/CombiMatrix
Average 90 stars, based on 1 article reviews
microarray imager software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
ice crispr analysis tool  (Synthego Inc)
86
Synthego Inc ice crispr analysis tool
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Ice Crispr Analysis Tool, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ice crispr analysis tool/product/Synthego Inc
Average 86 stars, based on 1 article reviews
ice crispr analysis tool - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
file maker software  (FileMaker Inc)
90
FileMaker Inc file maker software
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
File Maker Software, supplied by FileMaker Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/file maker software/product/FileMaker Inc
Average 90 stars, based on 1 article reviews
file maker software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
snp bead array  (GoldenGate Software Inc)
90
GoldenGate Software Inc snp bead array
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Snp Bead Array, supplied by GoldenGate Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snp bead array/product/GoldenGate Software Inc
Average 90 stars, based on 1 article reviews
snp bead array - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
dna microarray image analysis software  (Thermo Fisher)
99
Thermo Fisher dna microarray image analysis software
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Dna Microarray Image Analysis Software, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna microarray image analysis software/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
dna microarray image analysis software - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
molecular image gel doctm xr  (Bio-Rad)
96
Bio-Rad molecular image gel doctm xr
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Molecular Image Gel Doctm Xr, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecular image gel doctm xr/product/Bio-Rad
Average 96 stars, based on 1 article reviews
molecular image gel doctm xr - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
array file maker 4.0 software  (FileMaker Inc)
90
FileMaker Inc array file maker 4.0 software
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Array File Maker 4.0 Software, supplied by FileMaker Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array file maker 4.0 software/product/FileMaker Inc
Average 90 stars, based on 1 article reviews
array file maker 4.0 software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
array gauge software  (FUJIFILM)
90
FUJIFILM array gauge software
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Array Gauge Software, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array gauge software/product/FUJIFILM
Average 90 stars, based on 1 article reviews
array gauge software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
fcap array software version 3.0  (Becton Dickinson)
90
Becton Dickinson fcap array software version 3.0
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Fcap Array Software Version 3.0, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fcap array software version 3.0/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
fcap array software version 3.0 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
genotyping console 4.0 analysis  (Thermo Fisher)
90
Thermo Fisher genotyping console 4.0 analysis
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Genotyping Console 4.0 Analysis, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genotyping console 4.0 analysis/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
genotyping console 4.0 analysis - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
ingaas array detector  (Raptor Photonics)
90
Raptor Photonics ingaas array detector
Silencing of the DYSF gene by <t>CRISPR/Cas9</t> successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).
Ingaas Array Detector, supplied by Raptor Photonics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ingaas array detector/product/Raptor Photonics
Average 90 stars, based on 1 article reviews
ingaas array detector - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
microarray cel files  (Thermo Fisher)
94
Thermo Fisher microarray cel files
A. Differential expression of murine orthologs of HSA21 trisomic genes in Ts65 (17 16 )Dn hematopoietic cells . Heatmap diagram of log 2 fold expression changes for genes with detectable expression in <t>microarray</t> data from the LSK, CMP, GMP and MEP cells for comparison between Ts65DnErg +/+/+ and Erg +/+ genotypes. Trisomic genes with significantly upregulated gene expression in Ts65(17 16 )Dn cells using a false discovery rate of 5% are indicated in red with an asterix. B. Barcode plot demonstrating distribution of differentially expressed genes due specifically to trisomy of Erg (pairwise comparison Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 ; red bars: upregulated genes; blue bars: downregulated genes) relative to gene expression changes due to overall trisomy (pairwise comparison Ts65Dn/Erg +/+/+ versus Erg +/+ ) in LSK cells. C. Venn diagram of differentially regulated genes in LSK cells due to the effect of overall trisomy ( Ts65Dn/Erg +/+/+ versus Erg +/+ ), trisomy of Erg ( Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 ) and non-Erg trisomy (Ts65Dn/Erg +/+/Mld2 versus Erg +/+ ). Intersect of differentially expressed genes by t-stastistic using an FDR of < 5%; (red) intersect of differentially expressed genes due to trisomy and Erg trisomy; (yellow) non-intersecting differentially expressed genes due to trisomy; (blue) non intersecting differentially expressed genes due to trisomy of Erg . D. Dot plot of differentially expressed genes in LSK cells by t-statistic comparing expression differences resulting from overall trisomy ( Ts65Dn/Erg +/+/+ versus Erg +/+ ) to those specifically attributable to Erg trisomy ( Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 , left panel) and Erg trisomy compared to expression changes specific for non -Erg genes in trisomy (Ts65Dn/Erg +/+/Mld2 versus Erg +/+ , right panel). Genes identified in the Venn diagram (Fig 2C) are shown using the same color scheme suggesting a high degree of correlation between differentially expressed genes due to trisomy and Erg trisomy in LSK cells.
Microarray Cel Files, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray cel files/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
microarray cel files - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

Image Search Results


Silencing of the DYSF gene by CRISPR/Cas9 successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).

Journal: Scientific Reports

Article Title: Impaired myogenesis in limb girdle muscular dystrophy type 2B

doi: 10.1038/s41598-025-10205-9

Figure Lengend Snippet: Silencing of the DYSF gene by CRISPR/Cas9 successfully reduces the synthesis of the dysferlin protein in myotubes from the control cell line. ( A ) Immunofluorescence staining indicating the absence of DYSF in the edited cell line, and the presence of myosin, showing that the cells maintain their capacity to differentiate. ( B ) Protein detection by western blotting highlights the reduction of the dysferlin protein to the levels of the LGMD2B myotubes and shows a secondary reduction of the calpain-3 protein, a finding already observed in other LGMD2B patients. Internal WB control for protein content in each sample can be observed with labelling to dystrophin (DMD), dysferlin (DYSF) and calpain3 (CAPN3).

Article Snippet: Sanger sequencing was performed to identify possible mutations and estimate the efficiency of gene editing, and we analyzed the .abi resulting files in the online software ICE CRISPR Analysis Tool (Synthego, www.synthego.com/products/bioinformatics/crispr-analysis ).

Techniques: CRISPR, Control, Immunofluorescence, Staining, Western Blot

A. Differential expression of murine orthologs of HSA21 trisomic genes in Ts65 (17 16 )Dn hematopoietic cells . Heatmap diagram of log 2 fold expression changes for genes with detectable expression in microarray data from the LSK, CMP, GMP and MEP cells for comparison between Ts65DnErg +/+/+ and Erg +/+ genotypes. Trisomic genes with significantly upregulated gene expression in Ts65(17 16 )Dn cells using a false discovery rate of 5% are indicated in red with an asterix. B. Barcode plot demonstrating distribution of differentially expressed genes due specifically to trisomy of Erg (pairwise comparison Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 ; red bars: upregulated genes; blue bars: downregulated genes) relative to gene expression changes due to overall trisomy (pairwise comparison Ts65Dn/Erg +/+/+ versus Erg +/+ ) in LSK cells. C. Venn diagram of differentially regulated genes in LSK cells due to the effect of overall trisomy ( Ts65Dn/Erg +/+/+ versus Erg +/+ ), trisomy of Erg ( Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 ) and non-Erg trisomy (Ts65Dn/Erg +/+/Mld2 versus Erg +/+ ). Intersect of differentially expressed genes by t-stastistic using an FDR of < 5%; (red) intersect of differentially expressed genes due to trisomy and Erg trisomy; (yellow) non-intersecting differentially expressed genes due to trisomy; (blue) non intersecting differentially expressed genes due to trisomy of Erg . D. Dot plot of differentially expressed genes in LSK cells by t-statistic comparing expression differences resulting from overall trisomy ( Ts65Dn/Erg +/+/+ versus Erg +/+ ) to those specifically attributable to Erg trisomy ( Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 , left panel) and Erg trisomy compared to expression changes specific for non -Erg genes in trisomy (Ts65Dn/Erg +/+/Mld2 versus Erg +/+ , right panel). Genes identified in the Venn diagram (Fig 2C) are shown using the same color scheme suggesting a high degree of correlation between differentially expressed genes due to trisomy and Erg trisomy in LSK cells.

Journal: PLoS Genetics

Article Title: Early Lineage Priming by Trisomy of Erg Leads to Myeloproliferation in a Down Syndrome Model

doi: 10.1371/journal.pgen.1005211

Figure Lengend Snippet: A. Differential expression of murine orthologs of HSA21 trisomic genes in Ts65 (17 16 )Dn hematopoietic cells . Heatmap diagram of log 2 fold expression changes for genes with detectable expression in microarray data from the LSK, CMP, GMP and MEP cells for comparison between Ts65DnErg +/+/+ and Erg +/+ genotypes. Trisomic genes with significantly upregulated gene expression in Ts65(17 16 )Dn cells using a false discovery rate of 5% are indicated in red with an asterix. B. Barcode plot demonstrating distribution of differentially expressed genes due specifically to trisomy of Erg (pairwise comparison Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 ; red bars: upregulated genes; blue bars: downregulated genes) relative to gene expression changes due to overall trisomy (pairwise comparison Ts65Dn/Erg +/+/+ versus Erg +/+ ) in LSK cells. C. Venn diagram of differentially regulated genes in LSK cells due to the effect of overall trisomy ( Ts65Dn/Erg +/+/+ versus Erg +/+ ), trisomy of Erg ( Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 ) and non-Erg trisomy (Ts65Dn/Erg +/+/Mld2 versus Erg +/+ ). Intersect of differentially expressed genes by t-stastistic using an FDR of < 5%; (red) intersect of differentially expressed genes due to trisomy and Erg trisomy; (yellow) non-intersecting differentially expressed genes due to trisomy; (blue) non intersecting differentially expressed genes due to trisomy of Erg . D. Dot plot of differentially expressed genes in LSK cells by t-statistic comparing expression differences resulting from overall trisomy ( Ts65Dn/Erg +/+/+ versus Erg +/+ ) to those specifically attributable to Erg trisomy ( Ts65Dn/Erg +/+/+ versus Ts65Dn/Erg +/+/Mld2 , left panel) and Erg trisomy compared to expression changes specific for non -Erg genes in trisomy (Ts65Dn/Erg +/+/Mld2 versus Erg +/+ , right panel). Genes identified in the Venn diagram (Fig 2C) are shown using the same color scheme suggesting a high degree of correlation between differentially expressed genes due to trisomy and Erg trisomy in LSK cells.

Article Snippet: Affymetrix microarray CEL files containing gene expression profiles of human DS CD34 + CD38 - HSCs and multipotential progenitors [ ] were obtained from the Paterson Institute for Cancer Research at the University of Manchester and analysed with the affy (version 1.34) and limma software packages.

Techniques: Expressing, Microarray